675
panel
Re-imagining Investment in Antibiotics: Incentives Needed (Invite only)
The current environment has highlighted the important role of antibiotics and vaccines in our li
ves, economy, and future. As the pipeline of new antibiotics continues to dwindle, the need for incentives to attract capital becomes more urgent than ever.
+ Read More
panel
Supporting America's Young Adults: Mental Well-being Innovation and Adoption (Invite only)
COVID-19 has exacerbated rates of anxiety, depression, and suicidality that were already alarmin
gly high among young adults.
+ Read More
panel
Two Perspectives, One Goal: Strategies Across the Pacific for Healthy Longevity
By 2050, the global population of adults over age 60 will have doubled to two billion. Asian cou
ntries, including Japan, South Korea, Singapore, and China are experiencing explosive population aging, with the US not far behind.
+ Read More
panel
The Pandemic Through a Child's Eyes: Amplifying Adverse Childhood Experiences (ACEs)
The stress and strain of the COVID-19 pandemic may lead to long-term health problems indirectly
attributable to the virus. Trauma and toxic stress in childhood can actually change DNA, dramatically affecting the brain and other critical body systems.
+ Read More
panel
Are Resistant Infections the Next Pandemic? New Antibiotics Need New Incentives
Antibiotic treatment in COVID-19 patients is driving antimicrobial resistance (AMR) as secondary
infections emerge.
+ Read More
panel
Innovative Solutions in Long-Term Care Financing and Delivery
Access to affordable long-term care (LTC) grows more urgent as the United States population ages
. Seventy percent of Americans aged 65 and older will require LTC at some point.
+ Read More
panel
Bringing It All Together: Innovations in Technology to Change Treatment and Care
Across science, some of our greatest achievements have occurred at the nexus of disciplines. In
the field of medicine, however, bringing far-reaching scientific advances together remains a challenge.
+ Read More
panel
BRIDGE Initiative: Models to Support Lost Therapies (Invite only)
Biopharma companies face financial disincentives to develop drugs in certain therapeutic areas a
nd to repurpose existing drugs.
+ Read More
panel
The Future of Health Data: Where Are We Now and Where Are We Going?
New players using new technologies are entering the healthcare space, acquiring patient data tha
t is more in demand than ever. Health datasets are leveraged to develop tools for diagnosis, monitoring, tracking, and reporting of illnesses.
+ Read More
panel
Snap Judgment: Reducing Stigma and Normalizing Mental Health (Invite only)
Personal mental health issues have long been considered a taboo topic for public discussion. Too
often, sufferers keep their struggles secret from family, friends, and coworkers for fear of being shamed, judged, or stigmatized.
+ Read More